Skip to content

Preliminary Efficacy of an mHealth Intervention in West Africa

Preliminary Efficacy of an mHealth Intervention in West Africa

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07276321
Enrollment
150
Registered
2025-12-11
Start date
2025-11-03
Completion date
2027-08-30
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenic Spectrum Disorder

Brief summary

We are conducting a pilot feasibility and preliminary efficacy trial of a digital intervention for serious mental illness in West Africa. Participants will be recruited from a large psychiatric hospital in Ghana and randomized into one of three study conditions: 1) Treatment as usual; 2) FOCUS intervention; 3) G-FOCUS intervention.

Interventions

OTHERG-FOCUS

A cultural adaption of an evidence-based (USA populations tested) digital tool for serious mental illness

OTHERFOCUS

An evidence-based (USA populations tested) digital tool for serious mental illness.

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged 18 years of age or older 2. Speaks English 3. Outpatient receiving care at Accra Psychiatric Hospital 4. Diagnosis of Schizophrenic Spectrum Disorder 5. Owns a mobile device capable of downloading smartphone applications

Exclusion criteria

1. Hearing, vision, or motor impairment that would hamper their ability to participate in data collection 2. Serious intellectual or developmental disability that would hamper their ability to participate in data collection

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire-9 (PHQ-9)Baseline, 6 weeks, 12 weeksDepressive symptoms.
Generalized Anxiety Disorder 7-item (GAD-7)Baseline, 6 weeks, 12 weeksAnxiety severity
Revised Green et al Paranoid Thoughts ScaleBaseline, 6 weeks, 12 weeks
Hamilton Program for Schizophrenia Voices QuestionnaireBaseline, 6 weeks, 12 weeks

Countries

Ghana

Contacts

Primary ContactAlexa Beaulieu
beaulia@uw.edu253 261-8661

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026